References
- Prima BioMed announces strategic acquisition of Immutep SA. www.primabiomed.com.au/media/pm/2014/1173.php.
- Immutep website. www.immutep.org.
- Prima BioMed website. www.primabiomed.com.au/about_us.
- Novartis announces divestiture of influenza vaccines business to CSL for USD 275 million. www.novartis.com/newsroom/media-releases/en/2014/1865897.shtml.
- CSL to acquire Novartis’ influenza vaccine business. www.csl.com.au/s1/cs/auhq/1187378853299/news/1252899900233/prdetail.htm.
- Rosenmayr-Templeton L . Industry update. Ther. Deliv.5 (7), 749–755 (2014).
- Perrigo Company plc to acquire Omega Pharma NV for EUR 3.6 billion creating a top five global OTC company. www.prnewswire.com/news-releases/perrigo-company-plc-to-acquire-omega-pharma-nv-for-eur-36-billion-creating-a-top-five-global-otc-company-281745261.html.
- Bristol-Myers Squibb enters into agreement that provides an exclusive option to acquire F-star Alpha Ltd. and its novel HER2-targeted therapy. 10.28. www.f-star.com/documents/2014.10.28BristolMyersSquibb_000.pdf.
- F-star website . www.f-star.com/about.php.
- Intarcia and Servier sign Ex-US partnership for ITCA 650 in diabetes; Intarcia retains independence & full control of the US & Japan. http://intarcia.com/media/press-releases/2014-nov-12-ex-us-partnership.html.
- Intarcia therapeutics website . http://intarcia.com.
- Geron announces global strategic collaboration with Janssen to develop and commercialize Imetelstat. www.geron.com/Announcement-Janssen.
- The Geron company website . www.geron.com/management.
- Entry for Lumason on drugs @FDA . www.accessdata.fda.gov/drugsatfda_docs/nda/2014/203684Orig1s000Lbl.pdf.
- FDA approves a new ultrasound imaging agent . FDA news release. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418509.htm.
- Ebola virus disease Fact sheet N°103 Updated September 2014. www.who.int/mediacentre/factsheets/fs103/en/.
- Cases of Ebola diagnosed in the United States . www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/united-states-imported-case.html.
- EMA ready to start assessment of Ebola vaccines and treatments as soon as data are made available. www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002192.jsp&mid=WC0b01ac058004d5c1.
- EMA advises on development plan for GSK Ebola vaccine. www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002202.jsp&mid=WC0b01ac058004d5c1.
- Our contribution to the fight against Ebola. GSK website. www.gsk.com/en-gb/our-stories/health-for-all/our-contribution-to-the-fight-against-ebola/.
- NewLink Genetics Corporation . http://newlinkgenetics.com/.
- Johnson & Johnson announces major commitment to speed Ebola vaccine development and significantly expand production. www.jnj.com/news/all/Johnson-Johnson-Announces-Major-Commitment-to-Speed-Ebola-Vaccine-Development-and-Significantly-Expand-Production.
- Section on MVA-BN on Bavarian Nordic website. www.bavarian-nordic.com/what-we-do/technologies/mva-bn.aspx.
- Mapp Biopharmaceutical Inc . www.mappbio.com.
- Begley S . US requests production plans for Ebola drug ZMapp. www.reuters.com/article/2014/10/17/us-health-ebola-usa-zmapp-exclusive-idUSKCN0I624P20141017.
- Acacia Pharma announces positive Phase III results for APD421 in PONV. http://acaciapharma.com/index.php/news/acacia_pharma_announces_positive_phase_3_results_for_apd421_in_ponv.
- Acacia Pharma website. http://acaciapharma.com/index.php.
- Sanovas awarded seminal patent for novel radiation oncology drug/device platform. www.sanovas.com/index.php/company/press-releases.
- Sanovas website. www.sanovas.com/.
- Gerrans LJ Gunday EH . US8834544 (2014).
- ViaCyte receives US patent claiming alternative methods to manufacture pancreatic progenitor cells In Vitro. http://viacyte.com/news-events-2/news/.
- Agulnick AD . US8859286 (2014).